Market Overview
The Global Flow Cytometry Market size is estimated to have a market value of
USD 4,826.1 million in 2023 and is expected to reach
USD 9,478.9 million at a
CAGR of 7.8% during the forecasted period of 2023 to 2032.
Flow cytometry is a significantly used analytical method for the identity, analysis, and sorting of cells primarily based on their bodily and chemical characteristics. It is extensively applied in various fields, consisting of life sciences studies, scientific diagnostics, pharmaceuticals, and biotechnology.
So, the global flow cytometry market refers to the collective services and products associated with the utility of drift cytometry generation on a worldwide scale. The global drift cytometry market reflects the collective sports and advancements in technology geared toward information cell strategies and enhancing diagnostic and therapeutic procedures across diverse scientific disciplines.
Market Dynamic
The global flow cytometry market is characterized by a variety of dynamic factors that affect its growth and future prospects. This market is highly dynamic as it is shaped by a combination of factors such as new technological developments, regulatory changes, consumer preferences, economic factors etc. The global flow cytometry market continues to expand as it develops and rapid development of its applications in clinical diagnostics, research and drug development.
The ability of flow cytometers to analyze and classify individual cells makes them important in fields as diverse as immunology, hematology, oncology, and infectious diseases Global chronic diseases such as cancer and autoimmune disorders increase demand for flow cytometry and other diagnostic tools.
The role of technology in disease diagnosis, management and personalization of medicines supports this market growth.
Continuous technological advancements in flow cytometry equipment, reagents, and software contribute significantly to the growth of this market. Ongoing research to improve cell sensitivity, multi-sensing capabilities, integration of imaging technologies, and optimize the overall performance of flow cytometers will further drive this market growth.
Research Scope and Analysis
By Technology
The global flow cytometry market is categorized by two technologies, which are cell-based flow cytometry & bead-based flow cytometry. Among these, Cell-based flow cytometry takes the lead, as it holds 63.1% of the market share in 2023 and is projected to show promising growth in the upcoming years as well. Cell-based flow cytometry is a fundamental technology used in flow cytometers, offering a powerful method for analyzing and characterizing individual cells within a heterogeneous population of cells.
Cell-based flow cytometry is more popular as it allows the analysis of individual cells within a sample, providing detailed information about cell populations, including cell size, granularity, and the expression of specific markers which is crucial for understanding the heterogenous and complex nature of the biological samples.
Furthermore, cell-based flow cytometry is also used in cell sorting which allows the isolation of specific cell populations based on defined characteristics.
This technique is highly capable and valuable in various applications, including stem cell research, the isolation of rare cell types, and the purification of specific cell subsets for downstream analyses. The versatile nature and broad variety of applications of cell-based flow cytometry make it a cornerstone technology in life sciences, clinical diagnostics, and drug discovery.
By Product & Services
Based on products and services, reagents & consumables dominate this market as they hold the largest share in this market by 2023. As these products are used in daily business of flow cytometer, reagents and consumables are separate components need as applied in various applications and various assays such as immunophenotyping, cell sorting. Apoptosis assay, and cell viability assay.
Laboratories and research facilities constantly need these reagents and consumables to perform tests, analyze samples, and obtain data. Due to the various applications of flow cytometry, a variety of specialized reagents are required that are particularly suited to the analytical and diagnostic requirements such as fluorochromes and antibodies are important reagents used in flow cytometry. The availability of a wide range of fluorochromes and antibodies provides the flexibility and versatility of flow cytometry assays.
Furthermore, reagents and consumables represent a major source of revenue for companies operating in the flow cytometry market. Repeated reagent purchases help provide steady revenue for manufacturers and suppliers pushing the growth prospects of this market.
By Application
Clinical applications dominate the flow cytometry market in terms of application hold 47.9% of the market share in 2023 and are expected to show substantial growth in the forecasted period as well due to their technical versatility & effectiveness in addressing the critical need for cell sorting and characterization in the diagnosis, monitoring, and treatment of various medical conditions.
Flow cytometry also provides precise data on the analysis of cellular traits, allowing healthcare specialists and researchers to diagnose and display diseases with greater accuracy. In most cancer diagnoses, for example, waft cytometry is substantially used for the identification and characterization of unique cell populations, helping in the detection of extraordinary cells associated with various cancers. Flow cytometry is likewise extensively utilized in hematology for the analysis of blood cells, and the identity of particular cell kinds to decide their mobile populations and cellular function.
The growing range of patients stricken by various continual illnesses, which include most cancers and autoimmune disorders, drives the call for advanced diagnostic gear. In this regard, glide cytometry's ability to offer quantitative and qualitative information on mobile characteristics aligns with the diagnostic desires of these conditions which further drives the increase of this section into the global flow cytometry marketplace.
By End-User
In this segment, academic institutes dominate the global flow cytometry market as they hold the highest portion of this market in 2023 and are expected to show subsequent growth in the upcoming period of 2023 to 2032. Academic institutes dominate this segment as they are hubs of scientific research and development which is important for the global flow cytometry market to grow well. Flow cytometry is a very important tool for checking and understanding cells.
It's needed in many kinds of studies like those about the immune system, cell life, tiny creatures called microbes, and cancer research too. In their work, researchers often use a tool called flow cytometry for different experiments for data extraction. Also, academic institutes play a vital role in training the next generation of scientists, healthcare professionals, and researchers where they use educational & training programs that push the use of flow cytometry instruments and technologies and the growth of this market.
Additionally, Government funding for research projects is often channeled through academic institutions. These research grants and financial support from government agencies contribute to the acquisition and utilization of advanced technologies like flow cytometry in academic institutions.
The Flow Cytometry Market Report is segmented on the basis of the following:
By Technology
- Cell-based Flow Cytometry
- Bead-based Flow Cytometry
By Product & Services
- Reagents & Consumables
- Instruments
- Software
- Accessories
- Services
By Application
- Clinical Application
- Cancer Diagnosis
- Hematology
- Autoimmune Disease
- Organ Transplantation
- Others
- Industrial Application
- Research Application
- Pharmaceuticals
- Immunology
- Cell Sorting
- Apoptosis
- Cell Viability
- Others
By End-User
- Academic Institutes
- Clinical Testing Lab
- Commercial Organization
- Hospitals
- Others
Regional Analysis
North America dominates the global float cytometry market as it
holds 42.2% of the marketplace proportion in 2023 and is expected to show a subsequent increase in the approaching years of 2023 to 2032.
North America's dominance in the global flow cytometry market can be attributed to numerous factors including its well-developed research and improvement infrastructure, advanced healthcare surroundings, and the presence of major flow cytometer manufacturers.
Canada and the United States are big players in the global flow cytometry market because they have strong systems for research, and healthcare, and many flow cytometers manufacturers are located there. The United States and other parts of North America have many famous research places, universities, and medical centers. They all care about science studies and new inventions. This makes them want to make better technology like flow cytometry.
This area also has a well-built system of big biotech and drug companies. They are contributing a lot to the increasing need for advanced technology in searching, making, and testing new medicines. In this regard flow cytometry plays a crucial role in these processes, driving its growth in this region further. The presence of multiple major players in the flow cytometry market in this region fosters competitiveness and drives continuous improvement in products and services. This competition positively contributes to North America's leadership in the global flow cytometry market.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
The global flow cytometry market has a dynamic competitive landscape with many key players vying to exert their dominance in this market through innovative products and diverse offerings. These companies utilize inorganic & organic strategies for their market expansion. The inorganic strategies include research and development of new products and innovation while the organic strategies deal with partnerships, mergers & acquisitions. Further, the mergers & partnerships boost their market position and pave the way for the expansion of the market conditions.
The major companies in the global flow cytometry market offer different services such as BD Biosciences which offers a comprehensive range of instruments and reagents, Beckman Coulter under the Danaher umbrella provides advanced cell analysis solutions, and Thermo Fisher Scientific, a multinational company that offers an extensive range of instruments and software solutions.
Sony Biotechnology and Merck Group contribute to the market with innovative flow cytometry solutions, while Sysmex focuses on clinical diagnostics in haematology. These companies navigate the dynamic market through strategic collaborations and technological advancements, continually adapting to the ever-evolving industry demands which further boost the growth of the global flow cytometry market.
Some of the prominent players in the global Flow Cytometry Market are:
- Danaher Corp.
- Becton Dickinson & Company
- Sysmex Corp.
- Agilent Technologies Inc.
- Apogee Flow Systems Ltd.
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Stratedigm Inc.
- DiaSorin SpA
- Miltenyi Biotech
- Sony Biotechnology Inc.
- Other Key Players
COVID-19 Pandemic & Recession: Impact on the Global Flow Cytometry Market:
The COVID-19 pandemic and the recession that followed changed how well the world's flow cytometry market was doing. At the start of the pandemic, this market had problems with experiments and tests that use flow cytometry. This might have slowed down new things coming into the global flow cytometry market. In the pandemic time, lockdowns and travel limits changed what is available in supply chains. This affects how flow cytometry tools like reagents get made too.
Also, moving to work from home and limitations on going into labs may have changed how different lab tools like flow cytometry are used. Lab and research places had problems keeping working normally, which might affect the use of their tools.
The pandemic made people rethink how they use healthcare resources, focusing on getting better with COVID-19 problems. This change affected how money and focus were given to make flow cytometers. It also impacted studies on COVID-19 research.
Report Details
| Report Characteristics |
| Market Size (2023) |
USD 4,826.1 Mn |
| Forecast Value (2032) |
USD 9,478.9 Mn |
| CAGR (2023-2032) |
7.8% |
| Historical Data |
2017 - 2022 |
| Forecast Data |
2023 - 2032 |
| Base Year |
2022 |
| Estimate Year |
2023 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Technology (Cell-based Flow Cytometry and Bead-
based Flow Cytometry), By Product & Services
(Reagents & Consumables, Instruments, Software,
Accessories and Services), By Application (Clinical
Application, Industrial Application and Research
Application), By End-User (Academic Institutes,
Clinical Testing Lab, Commercial Organization,
Hospitals and Others) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
Danaher Corp., Becton Dickinson & Company, Sysmex
Corp., Agilent Technologies Inc., Apogee Flow
Systems Ltd., Bio-Rad Laboratories Inc., Thermo
Fisher Scientific Inc., Stratedigm Inc., DiaSorin SpA,
Miltenyi Biotech, Sony Biotechnology Inc., and Other
Key Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Flow Cytometry Market size is estimated to have a value of USD 4,826.1 million in 2023 and
is expected to reach USD 9,478.9 million by the end of 2032.
North America has the largest market share for the Global Flow Cytometry Market with a share of about
42.2% in 2023.
Some of the major key players in the Global Flow Cytometry Market are Danaher Corp., Becton
Dickinson & Company, Sysmex Corp., Agilent Technologies Inc., Apogee Flow Systems Ltd., Bio-Rad
Laboratories Inc., Thermo Fisher Scientific Inc., Stratedigm Inc., DiaSorin SpA, Miltenyi Biotech, Sony
Biotechnology Inc. and others.
The market is growing at a CAGR of 7.8 percent over the forecasted period.